综述

中期和晚期肝细胞肝癌联合治疗的效能:介入治疗,索拉非尼和新型小分子药物

Published at: 2015年第1卷第43期

Julio A. Gutierrez 1,2 , Robert G. Gish 3
1 Antiviral Research Center, Department of Infectious Disease, University of California, San Diego, La Jolla, California, USA
2 Division of Hepatology, University of Miami School of Medicine, Miami, USA
3 Robert G. Gish Consultants, LLC; St. Joseph’s Hospital and Medical Center, Phoenix, Arizona; University of Nevada, Las Vegas, Nevada, USA
请购买后进行阅读
comments powered by Disqus